Role of caveolin-1 in thyroid phenotype, cell homeostasis, and hormone synthesis: In vivo study of caveolin-1 knockout mice

American Journal of Physiology - Endocrinology and Metabolism

Volumn 297, Issue 2, 2009, Pages

  Senou, Maximin ^a   Costa, Maria José ^b   Massart, Claude ^b   Thimmesch, Matthieu ^a   Khalifa, Céline ^a   Poncin, Sylvie ^a   Boucquey, Marie ^a   Gérard, Anne Catherine ^a   Audinot, Jean Nicolas ^c   Dessy, Chantal ^a   Ruf, Jean ^d   Feron, Olivier ^a   Devuyst, Olivier ^a   Guiot, Yves ^a   Dumont, Jacques Emile ^b   Van Sande, Jacqueline ^b   Many, Marie Christine ^a  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^b UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^c LUXEMBOURG INSTITUTE OF SCIENCE AND TECHNOLOGY   (Luxembourg)

^d AIX MARSEILLE UNIVERSITY   (France)

Author keywords

Dual oxidase; Hydrogen peroxide; Iodide; Iodination; Oxidative stress; Thyrocytes; Thyroid hormone synthesis; Thyroperoxidase

Indexed keywords

CAVEOLIN 1; HYDROGEN PEROXIDE; IODINE; LIOTHYRONINE; RADIOACTIVE IODINE; SODIUM PERCHLORATE; THYROGLOBULIN; THYROID HORMONE; THYROID PEROXIDASE; THYROTROPIN; THYROXINE;

ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL DAMAGE; CELL FUNCTION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; FREE LIOTHYRONINE INDEX; FREE THYROXINE INDEX; GOITER; HOMEOSTASIS; HORMONE RELEASE; IMMUNOGOLD ELECTRON MICROSCOPY; IMMUNOHISTOCHEMISTRY; IODINATION; MOUSE; NONHUMAN; OXIDATIVE STRESS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN LOCALIZATION; THYROID CELL; THYROID HORMONE SYNTHESIS; TRANSMISSION ELECTRON MICROSCOPY;

EID: 68049101140     PISSN: 01931849     EISSN: 15221555     Source Type: Journal    
DOI: 10.1152/ajpendo.90784.2008     Document Type: Article

References (62)

1. Alary J, Gueraud F, Cravedi JP. Fate of 4-hydroxynonenal in vivo: disposition and metabolic pathways. Mol Aspects Med 24: 177-187, 2003.
2. Aldred MA, Ginn-Pease ME, Morrison CD, Popkie AP, Gimm O, Hoang-Vu C, Krause U, Dralle H, Jhiang SM, Plass C, Eng C. Caveolin-1 and caveolin-2, together with three bone morphogenetic protein-related genes, may encode novel tumor suppressors down-regulated in sporadic follicular thyroid carcinogenesis. Cancer Res 63: 2864-2871, 2003.
3. Aldred MA, Huang Y, Liyanarachchi S, Pellegata NS, Gimm O, Jhiang S, Davuluri RV, de la Chapelle A, Eng C. Papillary and follicular thyroid carcinomas show distinctly different microarray expression profiles and can be distinguished by a minimum of five genes. J Clin Oncol 22: 3531-3539, 2004.
4. Ameziane-El-Hassani R, Morand S, Boucher JL, Frapart YM, Apostolou D, Agnandji D, Gnidehou S, Ohayon R, Noel-Hudson MS, Francon J, Lalaoui K, Virion A, and Dupuy C. Dual oxidase-2 has an intrinsic Ca2+-dependent H2O2-generating activity. J Biol Chem 280: 30046-30054, 2005.
5. Audinot JN, Senou M, Migeon HN, Many MC. Visualisation of thyroid hormone synthesis by ion imaging. Applied Surface Sci 130: 1-8, 2008.
6. Barriere H, Chailley B, Chambard M, Selzner JP, Mauchamp J, Gabrion J. Cholesterol-rich microdomains in rat and porcine thyroid membranes involved in TSH-induced endocytotic processes. Acta Anat (Basel) 132: 205-215, 1988.
7. Benard B, Brault J. [Production of peroxide in the thyroid]. Union Med Can 100: 701-705, 1971.
8. Brazer SC, Singh BB, Liu X, Swaim W, Ambudkar IS. Caveolin-1 contributes to assembly of store-operated Ca2+ influx channels by regulating plasma membrane localization of TRPC1. J Biol Chem 278: 27208-27215, 2003.
9. Brooker G, Harper JF, Terasaki WL, Moylan RD. Radioimmunoassay of cyclic AMP and cyclic GMP. Adv Cyclic Nucleotide Res 10: 1-33, 1979.
10. Castaing R, Slodzian G. Microanalyse par emission ionique secondaire. Journal of Microscopy 1, 395-410, 1962.
11. Cohen AW, Razani B, Wang XB, Combs TP, Williams TM, Scherer PE, Lisanti MP. Caveolin-1-deficient mice show insulin resistance and defective insulin receptor protein expression in adipose tissue. Am J Physiol Cell Physiol 285, C222-C235, 2003.
12. Cohen AW, Schubert W, Brasaemle DL, Scherer PE, Lisanti MP. Caveolin-1expression is essential for proper nonshivering thermogenesis in brown adipose tissue. Diabetes 54: 679-686, 2005.
13. Costa MJ, Song Y, Macours P, Massart C, Many MC, Costagliola S, Dumont JE, Van Sande J, Vanvooren V. Sphingolipid-cholesterol domains (lipid rafts) in normal human and dog thyroid follicular cells are not involved in thyrotropin receptor signaling. Endocrinology 145: 1464-1472, 2004.
14. Costa MJ, Senou M, Van Rode F, Ruf J, Capello M, Dequanter D, Lothaire P, Dessy C, Dumont JE, Many MC, Van Sande J. Reciprocal negative regulation between thyrotropin/3′,5′-cyclic adenosine monophosphate-mediated proliferation and caveolin-1 expression in human and murine thyrocytes. Mol Endocrinol 21: 921-932, 2007.
15. Couet J, Li S, Okamoto T, Ikezu T, Lisanti MP. Identification of peptide and protein ligands for the caveolin-scaffolding domain. Implications for the interaction of caveolin with caveolae-associated proteins. J Biol Chem 272: 6525-6533, 1997.
16. De Deken X, Wang D, Many MC, Costagliola S, Libert F, Vassart G, Dumont JE, Miot F. Cloning of two human thyroid cDNAs encoding new members of the NADPH oxidase family. J Biol Chem 275: 23227-23233, 2000.
17. Den Hartog MT, De Boer M, Veenboer GJ, de Vijlder JJ. Generation and characterization of monoclonal antibodies directed against noniodinated and iodinated thyroglobulin, among which are antibodies against hormonogenic sites. Endocrinology 127: 3160-3165, 1990.
18. Depauw H, de Wolf M, van Dessel G, Hilderson HJ, Lagrou A, Dierick W. Fluidity characteristics of bovine thyroid plasma membranes. Biochim Biophys Acta 814: 57-67, 1985.
19. Drab M, Verkade P, Elger M, Kasper M, Lohn M, Lauterbach B, Menne J, Lindschau C, Mende F, Luft FC, Schedl A, Haller H, Kurzchalia TV. Loss of caveolae, vascular dysfunction, and pulmonary defects in caveolin-1 gene-disrupted mice. Science 293: 2449-2452, 2001.
20. Dremier S, Golstein J, Mosselmans R, Dumont JE, Galand P, Robaye B. Apoptosis in dog thyroid cells. Biochem Biophys Res Commun 200: 52-58, 1994.
21. Fortemaison N, Miot F, Dumont JE, Dremier S. Regulation of H2O2 generation in thyroid cells does not involve Rac1 activation. Eur J Endocrinol 152: 127-133, 2005.
22. Franklyn JA. Subclinical thyroid disorders - consequences and implications for treatment. Ann Endocrinol (Paris) 68: 229-230, 2007.
23. Fujita H, Ishimura K, Matsuda H. Freeze-fracture images on filipin-sterol complexes in the thyroid follicle epithelial cell of mice with special regard to absence of cholesterol at the site of micropinocytosis. Histochemistry 73: 57-63, 1981.
24. Gerard AC, Xhenseval V, Colin IM, Many MC, Denef JF. Evidence for co-ordinated changes between vascular endothelial growth factor and nitric oxide synthase III immunoreactivity, the functional status of the thyroid follicles, and the microvascular bed during chronic stimulation by low iodine and propylthiouracyl in old mice. Eur J Endocrinol 142: 651-660, 2000.
25. Gerard AC, Many MC, Daumerie C, Costagliola S, Miot F, Devijlder JJ, Colin IM, Denef JF. Structural changes in angiofollicular units between active and hypofunctioning follicles align with differences in the epithelial expression of newly discovered proteins involved in iodine transport and organification. J Clin Endocrinol 87: 1294-1299, 2002.
26. Gerard AC, Many MC, Daumerie C, Knoops B, Colin IM. Peroxiredoxin 5 expression in the human thyroid gland. Thyroid 15: 205-209, 2005.
27. Gerard AC, Poncin S, Caetano B, Sonveaux P, Audinot JN, Feron O, Colin IM, Soncin F. Iodine deficiency induces a thyroid stimulating hormone-independent early phase of microvascular reshaping in thyroid. Am J Pathol 172: 748-60, 2008.
28. Guerquin-Kern JL, Hillion F, Madelmont JC, Labarre P, Papon J, Croisy A. Ultra-structural cell distribution of the melanoma marker iodobenzamide: improved potentiality of SIMS imaging in life sciences. Biomed Eng Online 3: 1-7, 2004.
29. Head BP, Insel PA. Do caveolins regulate cells by actions outside of caveolae? Trends Cell Biol 17: 51-57, 2007.
30. Hilenski LL, Clempus RE, Quinn MT, Lambeth JD, Griendling KK. Distinct subcellular localizations of Nox1 and Nox4 in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 24: 677-683, 2004.
31. Hnasko R, Lisanti MP. The biology of caveolae: lessons from caveolin knockout mice and implications for human disease. Mol Interv 3: 445-464, 2003.
32. Insel PA, Patel HH. Do studies in caveolin knockouts teach us about physiology and pharmacology or instead, the ways mice compensate for 'loss protein'? Br J Pharmacol 150: 251-254, 2007.
33. Kurzchalia TV, Dupree P, Parton RG, Kellner R, Virta H, Lehnert M, Simons K. VIP21, a 21-kD membrane protein is an integral component of trans-Golgi-network-derived transport vesicles. J Cell Biol 118: 1003-1014, 1992.
34. Le Lay S, Kurzchalia TV. Getting rid of caveolins: phenotypes of caveolin-deficient animals. Biochim Biophys Acta 1746: 322-333, 2005.
35. Li J, Scherl A, Medina F, Frank PG, Kitsis RN, Tanowitz HB, Sotgia F, Lisanti MP. Impaired phagocytosis in caveolin-1 deficient macrophages. Cell Cycle 4: 1599-1607, 2005.
36. Lipardi C, Mora R, Colmer V, Paladino S, Nitsch L, Rodriguez-Boulan E, Zurzolo C. Caveolin transfection results in caveolae formation but not apical sorting of glycosylphosphatidylinositol (GPI)-anchored proteins in epithelial cells. J Cell Biol 140: 617-626j, 1998.
37. Mora R, Bonihla VL, Marmostein A, Scherer PE, Brown D, Lisanti MP, Rodriguez-Boulan E. Caveolin-2 localizes to the golgi complex but redistributes to plasma membrane, caveolea, and rafts when coexpressed with caveolin-1. J Biol Chem 274: 25708-25717, 1999.
38. Palade GE. Fine structure of blood capillaries. J Appl Physiol 24: 1424-1436, 1953.
39. Park DS, Cohen AW, Frank PG, Razani B, Lee H, Williams TM, Chandra M, Shirani J, De Souza AP, Tang B, Jelicks LA, Factor SM, Weiss LM, Tanowitz HB, Lisanti MP. Caveolin-1 null (-/-) mice show dramatic reductions in life span. Biochemistry 42: 15124-15131, 2003.
40. Parton RG, Hanzal-Bayer M, Hancock JF. Biogenesis of caveolae: a structural model for caveolin-induced domain formation. J Cell Sci 119: 787-796, 2006.
41. Perret J, Ludgate M, Libert F, Gerard C, Dumont JE, Vassart G, Parmentier M. Stable expression of the human TSH receptor in CHO cells and characterization of differentially expressing clones. Biochem Biophys Res Commun 171: 1044-1050, 1990.
42. Peteranderl R, Lechene C. Measure of carbon and nitrogen stable isotope ratios in cultured cells. J Am Soc Mass Spectrom 15: 478-485, 2004.
43. Petersen DR, Doorn JA. Reactions of 4-hydroxynonenal with proteins and cellular targets. Free Radic Biol Med 37: 937-945, 2004.
44. Pohlenz J, Maqueem A, Cua K, Weiss RE, Van Sande J, Reffetoff S. Improved radioimmunoassay for measurement of mouse thyrothropin in serum: strain difference in thyrotropin concentration and thyrotroph sensitivity to thyroid hormone. Thyroid 9: 1265-1271, 1999.
45. Razani B, Combs TP, Wang XB, Frank PG, Park DS, Russell RG, Li M, Tang B, Jelicks LA, Scherer PE, Lisanti MP. Caveolin-1-deficient mice are lean, resistant to diet-induced obesity, and show hypertriglyceridemia with adipocyte abnormalities. J Biol Chem 277: 8635-8647, 2002.
46. Razani B, Engelman JA, Wang XB, Schubert W, Zhang XL, Marks CB, Macaluso F, Russell RG, Li M, Pestell RG, Di Vizio D, Hou H Jr, Kneitz B, Lagaud G, Christ GJ, Edelmann W, Lisanti MP. Caveolin-1 null mice are viable but show evidence of hyperproliferative and vascular abnormalities. J Biol Chem 276: 38121-38138, 2001.
47. Razani B, Woodman SE, Lisanti MP. Caveolae: from cell biology to animal physiology. Pharmacol Rev 54: 431-467, 2002.
48. Rhee SG, Chae HZ, Kim K. Peroxiredoxins: a historical overview and speculative preview of novel mechanisms and emerging concepts in cell signaling. Free Radic Biol Med 38: 1543-1552, 2005.
49. Ring A, Le Lay S, Pohl J, Verkade P, Stremmel W. Caveolin-1 is required for fatty acid translocase (FAT/CD36) localization and function at the plasma membrane of mouse embryonic fibroblasts. Biochim Biophys Acta 1761: 416-423, 2006.
50. Rodesch F, Neve P, Willems C, Dumont JE. Stimulation of thyroid metabolism by thyrotropin, cyclic 3′:5′-AMP, dibutyryl cyclic 3′:5′-AMP and prostaglandin E1. Eur J Biochem 8: 26-32, 1969.
51. Rothberg KG, Heuser JE, Donzell WC, Ying YS, Glenney JR, Anderson RG. Caveolin, a protein component of caveolae membrane coats. Cell 68: 673-682, 1992.
52. Ruf J, Toubert ME, Czarnocka B, Durand-Gorde JM, Ferrand M, Carayon P. Relationship between immunological structure and biochemical properties of human thyroid peroxidase. Endocrinology 125: 1211-1218, 1989.
53. Simons K, Ikonen E. Functional rafts in cell membranes. Nature 387: 569-572, 1997.
54. Song Y, Driessens N, Costa M, De D, X, Detours V, Corvilain B, Maenhaut C, Miot F, Van Sande J, Many MC, Dumont JE. Roles of hydrogen peroxide in thyroid physiology and disease. J Clin Endocrinol Metab 92: 3764-3773, 2007.
55. Trushina E, Du CJ, Parisi J, McMurray CT. Neurological abnormalities in caveolin-1 knock out mice. Behav Brain Res 172: 24-32, 2006.
56. Unger J, Boeynaems JM, Van Herle A, Van Sande J, Rocmans P, Mockel J. In vitro nonbutanol-extractable iodine release in dog thyroid. Endocrinology 105: 225-231, 1979.
57. Wang MX, Wei A, Yuan J, Clippe A, Bernard A, Knoops B, Murrell GA. Antioxidant enzyme peroxiredoxin 5 is upregulated in degenerative human tendon. Biochem Biophys Res Commun 284: 667-673, 2001.
58. Wattel S, Mircescu H, Venet D, Burniat A, Franc B, Frank S, Andry G, Van Sande J, Rocmans P, Dumont JE, Detours V, Maenhaut C. Gene expression in thyroid autonomous adenomas provides insight into their physiopathology. Oncogene 24: 6902-6916, 2005.
59. Wikstrom L, Johansson C, Salto C, Barlow C, Campos BA, Baas F, Forrest D, Thoren P, Vennstrom B. Abnormal heart rate and body temperature in mice lacking thyroid hormone receptor alpha 1. EMBO J 17: 455-461, 1998 .
60. Wyse BD, Prior IA, Qian H, Morrow IC, Nixon S, Muncke C, Kurzchalia TV, Thomas WG, Parton RG, Hancock JF. Caveolin interacts with the angiotensin II type 1 receptor during exocytic transport but not at the plasma membrane. J Biol Chem 278: 23738-23746, 2003.
61. Yamada E. The fine structure of the gall bladder epithelium of the mouse. J Biophys Biochem Cytol 1: 445-458, 1955.
62. Zuo L, Ushio-Fukai M, Ikeda S, Hilenski L, Patrushev N, Alexander RW. Caveolin-1 is essential for activation of rac1 and NAD(P)H oxidase after angiotensin II type 1 receptor stimulation in vascular smooth muscle cells. Role in redox signaling and vascular hypertrophy. Arterioscler Thromb Vasc Biol 25: 1824-1830 2005.